Dried blood spot in the genotyping, quantification and storage of HCV RNA: a systematic literature review
Where we are with point-of-care testing
Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies
Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C
Elevated interferon-stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virus
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation
HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact
Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey
Hepatitis B virus (HBV) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (CHB) disease phases
Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus
Single-nucleotide substitution of Hepatitis B virus in intrauterine infection
HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy
Five-year follow-up of immune response after one or two doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina